Clinical Social Workers in Gladstone, OR Accepting Medicare

10 Clinical Social Workers found. Showing 1 - 10

Diana Grum, MSSA, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 870 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515

Dr. Elizabeth Daffer Smith, PHD, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 555 Stonehill Dr, Gladstone, OR 97027 Phone: 971-303-8464

Ms. Sandra Roskott, LCSW, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 685 Portland Ave, Gladstone, OR 97027 Phone: 662-626-3303

Jane E. Huey, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 880 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515    Fax: 503-659-1994

Kimberlin Santos, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 890 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515    Fax: 503-212-2292

Mrs. Kathleen Marie Egli, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 880 82nd Dr Bldg B, Gladstone, OR 97027 Phone: 503-233-5405    Fax: 503-233-2694

Magaly Guzman, CSWA, LWAIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 880 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515    Fax: 503-659-1994

Margaret Lee Mahlik, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 19220 Mcloughlin Blvd, Gladstone, OR 97027 Phone: 503-655-2404    Fax: 503-655-1581

Ms. Wendy Jo Ballard-turner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 18905 Portland Ave, Gladstone, OR 97027 Phone: 503-496-3939

Heather Rebecca Whitney, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 880 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515

News Archive

Onyx announces results from regorafenib Phase 3 trial on GIST

Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.

JournalGuide: A free tool to help researchers choose best journal for manuscript

JournalGuide - a free tool created by Research Square to help researchers choose the best journal for their manuscript - has added a new designation to its database to help authors identify the most reputable publishing options.

Study highlights pollution exposure of babies in prams

Babies in prams can be exposed to up to 60 percent more pollution than their parents, causing potential damage to their frontal lobe and impacting on their cognitive abilities and brain development.

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest cancers affecting only 1 in 100,000 people.

Industries oppose proposed assisted living regulations

With Pennsylvania just weeks away from the publication of final assisted living regulations, recently-released survey results about the size of living units in existing facilities show the wisdom of the proposed rules - and the absurdity of the industry's opposition.

Read more Medical News

› Verified 8 days ago